首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1672756

過敏性鼻炎治療市場：依治療類型、給藥途徑、通路及地區分類

Allergic Rhinitis Treatment Market, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2025年02月13日 | 出版商:

Coherent Market Insights | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球過敏性鼻炎治療市場規模估計為 169.1 億美元，預計到 2032 年將達到 238.1 億美元，2025 年至 2032 年的複合年成長率為 5.0%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	169.1億美元
效能資料	從 2020 年到 2024 年	預測期	2025 至 2032 年
預測期：2025-2032年複合年成長率：	5.00％	2032 年價值預測	238.1億美元

數字。 2025 年過敏性鼻炎治療市場佔有率（按地區分類）

過敏性鼻炎，俗稱花粉症，是身體對一種或多種空氣傳播的過敏原（如花粉或灰塵）的發炎反應。它會引起打噴嚏、流鼻水、鼻塞和眼睛發癢等症狀。近年來，由於環境污染加劇、生活方式改變等因素，全球過敏性鼻炎的盛行率穩定上升。據估計，目前全球約有10-30％的人口患有過敏性鼻炎，這是一個重大的健康問題。由於人們對過敏性鼻炎認知的不斷提高和診斷水平的提高，過敏性鼻炎藥物的市場也在大幅成長。

市場動態：

全球過敏性鼻炎治療市場的成長受到全球過敏性鼻炎患者盛行率上升的推動。此外，由於環境污染程度加劇和天氣模式變化導致花粉等空氣過敏原激增，市場正在經歷強勁成長。診斷和治療方法的進步以及製藥公司在過敏研究方面的投入增加，推動了新產品的推出，從而促進了市場成長。然而，重磅藥物品牌專利到期及學名藥的出現預計將在一定程度上阻礙創新藥製造商的成長。然而，印度和中國等人口眾多且患有過敏症的新興經濟體可能會在未來幾年為市場參與者提供有利可圖的機會。

本研究的主要特點

本報告對全球過敏性鼻炎治療市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設 2024 年為基準年。
它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
全球過敏性鼻炎治療市場的主要企業根據公司亮點、產品系列、關鍵亮點、績效和策略等參數進行分析。
主要公司包括默克公司、勃林格殷格翰國際有限公司、阿斯特捷利康公司、葛蘭素史克公司、強生服務公司、梯瓦製藥工業有限公司、諾華公司、邁蘭公司、Aytu BioPharma 公司、再生元製藥公司、Revolo Biotherapeutics、雷迪歐實驗室有限公司、Glenmark 製藥有限公司、拜耳藥廠、Alembic 有限公司。
本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球過敏性鼻炎治療市場迎合了該行業的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球過敏性鼻炎治療市場的各種策略矩陣來促進決策。

公司簡介
- Merck &Co., Inc.
- Boehringer Ingelheim International GmbH
- AstraZeneca
- GSK plc.
- Johnson &Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Mylan NV
- Aytu BioPharma, Inc.
- Regeneron Pharmaceuticals Inc.
- Revolo Biotherapeutics
- Dr. Reddy's Laboratories Ltd
- Glenmark Pharmaceuticals Ltd
- Bayer AG
- Alembic Pharmaceuticals Limited
- Sanofi
- Hikma Pharmaceuticals PLC

第 10 章分析師觀點

第 11 章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI1201

Global Allergic Rhinitis Treatment Market is estimated to be valued at USD 16.91 Bn in 2025 and is expected to reach USD 23.81 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.0% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 16.91 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.00%	2032 Value Projection:	USD 23.81 Bn

Figure. Allergic Rhinitis Treatment Market Share (%), By Region 2025

Allergic Rhinitis Treatment Market - IMG1

Allergic rhinitis, commonly known as hay fever, is a condition where the body exhibits an inflammatory response to one or more airborne allergens like pollen or dust. It causes symptoms like sneezing, runny nose, nasal congestion and itchy eyes. The global prevalence of allergic rhinitis has been steadily increasing in recent years due to factors like increasing environmental pollution and changes in lifestyle. According to some estimates, about 10-30% of the global population currently suffers from allergic rhinitis, making it a major health concern. With growing awareness and better diagnosis, the market for drugs to treat allergic rhinitis has also expanded significantly.

Market Dynamics:

The global allergic rhinitis treatment market is driven by the rising prevalence of allergic rhinitis cases globally. The market has also witnessed robust growth due to the increasing environmental pollution levels and changing climate patterns which have led to the proliferation of airborne allergens like pollen. Advancements in diagnosis and treatment options along with higher investments in allergy research by pharmaceutical companies are translating into new product launches and boosting the market growth. However, patent expiries of blockbuster drug brands coupled with the availability of generic alternatives are expected to hamper the growth of innovator drug makers to some extent. Nevertheless, emerging economies like India and China with their huge population base suffering from allergies present lucrative opportunities for market players in the coming years.

Key Features of the Study:

This report provides an in-depth analysis of the global allergic rhinitis treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global allergic rhinitis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Merck & Co., Inc., Boehringer Ingelheim International GmbH, AstraZeneca, GSK plc., Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Aytu BioPharma, Inc., Regeneron Pharmaceuticals Inc., Revolo Biotherapeutics, Dr. Reddy's Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Bayer AG, Alembic Pharmaceuticals Limited, Sanofi, Hikma Pharmaceuticals PLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global allergic rhinitis treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergic rhinitis treatment market.

Detailed Segmentation-

By Treatment Type:
- Immunotherapy
- Sub-cutaneous Immunotherapy (SCIT)
- Sub-lingual Immunotherapy (SLIT)
- Anti-histamines
- Decongestants
- Leukotriene Receptor Antagonists
- Corticosteroids
- Others
By Route of Administration:
- Oral
- Nasal
- Intraocular
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- E-commerce
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- AstraZeneca
- GSK plc.
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Mylan N.V.
- Aytu BioPharma, Inc.
- Regeneron Pharmaceuticals Inc.
- Revolo Biotherapeutics
- Reddy's Laboratories Ltd
- Glenmark Pharmaceuticals Ltd
- Bayer AG
- Alembic Pharmaceuticals Limited
- Sanofi
- Hikma Pharmaceuticals PLC

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Pipeline Analysis
Epidemiology
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Brand and Pricing Analysis
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Allergic Rhinitis Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Allergic Rhinitis Treatment Market, By Treatment Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sub-cutaneous Immunotherapy (SCIT)
Sub-lingual Immunotherapy (SLIT)
Anti-histamines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Decongestants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Leukotriene Receptor Antagonists
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Allergic Rhinitis Treatment Market, By Route of Administration, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nasal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intraocular
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Allergic Rhinitis Treatment Market, By Distribution Channel, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
E-commerce
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Allergic Rhinitis Treatment Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim International GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSK plc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Mylan N.V.
- Aytu BioPharma, Inc.
- Regeneron Pharmaceuticals Inc.
- Revolo Biotherapeutics
- Dr. Reddy's Laboratories Ltd
- Glenmark Pharmaceuticals Ltd
- Bayer AG
- Alembic Pharmaceuticals Limited
- Sanofi
- Hikma Pharmaceuticals PLC